Rupert Vessey
Bio-Techne appointed Rupert Vessey as an independent director to its board of directors, bringing the total number of board members to nine.
He is the president of global research and early development at Celgene. Before joining Celgene, Vessey held various R&D senior management positions at Merck. Previously, he worked in drug discovery, experimental medicine, and early clinical development at GlaxoSmithKline.